Trial intelligence / Profile preview

Anakinra in COVID-19 with Worsening Respiratory Symptoms

NCT04364009Phase 3Terminated

Sponsor
University Hospital Tours
Start
Apr 2020
Primary completion
Oct 2020
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of anakinra in coronavirus disease 2019 (COVID-19), sponsored by University Hospital Tours. Started Apr 2020; status: terminated.

02

Drugs

anakinra
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04364009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04364009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call